| Barchart Demo Center |
$147.12
-0.02 (-0.01%)
as of May 31, 2024
as of May 31, 2024
| Profile | |
|---|---|
| Ticker Symbol | DVA |
| Exchange | NYSE |
| Contact Information |
2000 16TH STREET DENVER, CO USA P: 720-631-2100 |
| CEO/President | Javier J. Rodriguez |
| Earnings at a Glance | ||||
|---|---|---|---|---|
| Earnings | 03/31/24 2.73 |
12/31/23 1.68 |
09/30/23 2.70 |
06/30/23 1.96 |
| Price Earnings Ratio | 15.98 | |||
| EPS Growth | 13.63 | |||
| Most Recent Earnings ($) | 2.65 | |||
| Annual EPS ($) | 8.80 | |||
| Business Summary | |
|---|---|
| DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services pharmacy services infusion therapy services disease management services vascular access services ESRD clinical research programs and physician services. | |
| Industry/Sector | SIC-8090 Services-Misc Health & Allied Services, NEC Indices S&P 500 Medical - Outpatient & Hm Care Indices Russell 3000 Indices Russell 1000 Indices S&P 500 ESG Indices S&P 500 Value Indices S&P 500 Growth Indices S&P 500 Health Care |